PBM
NASDAQ
CA
Psyence Biomedical Ltd. - Common Shares
$2.47
▲ +$0.10
(+4.22%)
Vol 28K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.4M
P/E
5.5
ROE
-6.4%
D/E
0.00
Beta
0.27
52W
$1–$20
Price Chart
Fundamentals Trend
| Metric | 2025-03-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 1.4% | 1.4% | 1.4% | 1.4% | -6.3% |
| P/E (TTM) | — | — | — | — | — | 5.46 |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 80.60 | 80.60 | 80.60 | 80.60 | 0.00 |
| Current Ratio | 11.04 | 0.09 | 0.09 | 0.09 | 0.09 | 8.09 |
Key Ratios
ROA (TTM)
-5.9%
P/B
0.4
EPS (TTM)
$41.27
52W High
$20.24
52W Low
$0.80
$0.80
52-Week Range
$20.24
How does PBM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PBM valuation vs Biotechnology peers
P/E ratio
5.5
▼
71%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼
84%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PBM profitability vs Biotechnology peers
ROE
-6.4%
▲
91%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-5.9%
▲
87%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PBM financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.1
▲
82%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼
72%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
PBM fundamentals radar
PBM
Peer median
Industry
PBM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PBM vs peers: key metrics
Latest News
Bernstein Bullish on The Cigna Group (CI) Amid Leadership Change and Improved …
Yahoo Finance · Apr 01
CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to …
Yahoo Finance · Apr 01
Bernstein Upgrades The Cigna Group (CI) From “Market Perform” to “Outperform”
Yahoo Finance · Mar 18